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clamping as well as reperfusion following declamping re-
sults in disorders in almost all organ systems both proxi-
mal and distal to the aortic clamp  [1] . Following 
abdominal aortic surgery, splanchnic ischaemia was doc-
umented histologically in 30% of patients  [2] , and im-
paired splanchnic perfusion may contribute to postop-
erative complications  [3] . Recent studies have demon-
strated beneﬁ cial effects on the splanchnic circulation 
using dopexamine in animal models of haemorrhagic 
shock  [4] , endotoxaemia  [5] , and during positive pressure 
ventilation  [6] . Accordingly, dopexamine was investi-
gated in patients undergoing abdominal infrarenal aortic 
surgery  [7–9] as a preventive measure to reduce periop-
erative splanchnic ischaemia. 
 The rationale to use dopexamine is given by its action 
on dopaminergic (DA-1) and    2 -adrenoreceptors, result-
ing in splanchnic vasodilatation  [10] , and by its indirect 
action on    1 -adrenoreceptors due to inhibition of norepi-
nephrine reuptake  [11] , resulting in positive inotropic ef-
fects. The combined effects may lead to increased splanch-
nic as well as systemic blood ﬂ ows without changing the 
fractional splanchnic blood ﬂ ow  [12] . Besides haemody-
namic effects, adrenergic drugs have metabolic conse-
quences  [13, 14] , which may limit potentially beneﬁ cial 
haemodynamic effects  [15] . Using a rat model of aortic 
cross-clamping, we recently observed higher blood lactate 
levels when dopexamine, and lower blood lactate levels 
when dopamine was continuously infused  [16] . The in-
terpretation of these unexpected ﬁ ndings was limited, 
since the dopexamine dose was higher than in compara-
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 Abstract 
 This experimental study in rats was designed to demon-
strate effects of dopexamine (3   g kg –1  min –1 , n = 6) or 
physiologic saline solution (n = 6) on systemic as well as 
regional perfusion during 30 min of supracoeliac aortic 
cross-clamping and during 180 min of reperfusion fol-
lowing declamping. Rats were surgically instrumented 
with arterial, right atrial and portal venous catheters, ul-
trasonic fl ow probes around the abdominal aorta, supe-
rior mesenteric and carotid artery, and a paediatric to-
nometer for intestinal mucosal PCO 2  measurement. 
During 120 min of reperfusion, fl uid resuscitation was 
titrated to keep abdominal aortic blood fl ow above 80% 
of baseline values. We found that during cross-clamping, 
values of arterial lactate (p = 0.002) and intestinal tono-
metric PCO 2  (p = 0.018) were higher in the dopexamine 
group than in the control group. 
 Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 Cross-clamping of the abdominal aorta may be applied 
during aortic reconstructive surgery and during resuscita-
tion of trauma. Acute ischaemia during aortic cross-
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ble experimental studies. Furthermore, ﬂ uid resuscita-
tion during reperfusion was not adequate to normalize 
haemodynamic variables following declamping. There-
fore, we performed a study using a lower dose of dopex-
amine and a modiﬁ ed ﬂ uid resuscitation protocol, which 
aimed to keep the aortic blood ﬂ ow during reperfusion 
above 80% of respective preclamp baseline values. Based 
on our previous ﬁ ndings, we hypothesized that continu-
ous infusion of dopexamine might induce higher levels of 
blood lactate during aortic cross-clamping. 
 Methods 
 The studies were approved by the local Animal Care Commit-
tee and the procedures fully complied with the Swiss animal protec-
tion laws  [17] . 
 Animal Preparation 
 Twelve male Sprague-Dawley rats (Biological Research Labo-
ratories Ltd., Fuellinsdorf, Switzerland), weighing 420  8 20 g and 
3–3.5 months old, were kept in a regulated animal facility, super-
vised by state veterinarians. Animals were fasted overnight with 
free access to water before the experiment. Anaesthesia was in-
duced by putting the animals into a chamber which was ﬁ lled with 
3% halothane in 100% oxygen for 5 min, followed by intraperito-
neal injection of pentobarbital (45 mg kg –1 ) and maintained with 
intravenous pentobarbital (20 mg kg –1  h –1 ) and fentanyl (5   g kg –1  
h –1 ), both diluted in a 5% solution of human albumin (HA) and 
given as a continuous infusion (8 ml kg –1  h –1 ) throughout the ex-
periment. No neuromuscular blocking drugs were given. 
 After local anaesthesia with 1% lidocaine hydrochloride, the 
proximal trachea was surgically exposed and a 14-gauge cannula 
(Abbocath-T Venosystems, Abbott, Cork, Ireland) was inserted 
through a tracheotomy. Ventilation was established with tidal 
 volumes of 0.65 ml 100 g –1  body weight at a frequency of 80–
100 min –1  (Model 680, Harvard Biosciences, South Natick, Mass., 
USA) and an air/oxygen mixture resulting in an FiO 2  of 0.4. End-
tidal CO 2  was measured with a side stream infrared CO 2  monitor 
(CD-102 Normocap, Datex Inc., Helsinki, Finland) at a low ﬂ ow 
rate (50 ml min –1 ) to document adequate ventilatory patterns. The 
rectal temperature was monitored and kept at 37  °  C (standard de-
viation 0.5) using a heating lamp.  
 Polyethylene cannulas (0.58 mm ID, 0.96 mm OD; Portex, Eng-
land) were inserted into the left carotid artery for monitoring mean 
arterial pressure (MAP) and sampling arterial blood, and via the 
left jugular vein into the right atrium for sampling right atrial ve-
nous blood as well as ﬂ uid and drug administration. For portal vein 
blood sampling, an ileocecal vein was isolated under microscope, 
ligated distally and cannulated with a polyethylene catheter 
(0.28 mm ID, 0.61 mm OD; Portex). The tip of the catheter was 
advanced until 1 cm below the liver hilus. Abdominal aortic, supe-
rior mesenteric arterial, and right carotid arterial blood ﬂ ows were 
measured using a transonic ﬂ ow meter (T207, Transonic Systems 
Inc., N.Y., USA). The blood vessels were exposed and separated 
for a 5- to 8-mm free segment. A 1-mm ﬂ ow probe (model 1RB1506) 
was placed around the carotid artery, a 1.5-mm probe (model 
1.5RB99) around the superior mesenteric artery close to its origin 
to the aorta, and a 3-mm probe (model 3SB777) around the ab-
dominal aorta below diaphragm but above branching of the coeliac 
artery. Surgical dissection of the abdominal aorta was performed 
such that there was enough space to place the ﬂ ow probe and a vas-
cular clamp with brackets, covered by rubber tubes to prevent tissue 
damage, at the supracoeliac level and proximal to the ﬂ ow probe. 
A jejunal loop, which is supplied uniquely by the superior mesen-
teric artery, was identiﬁ ed and a paediatric 5-french nasogastric 
silicon balloon tonometer (Tonometrics, Charlottenlund, Den-
mark) was inserted into the intestinal lumen via a small enteroto-
my. The abdomen was closed with clamps and the animals were 
allowed to stabilize for 30 min. 
 Fluid Management 
 Throughout the experimental procedure, a continuous infusion 
of HA (8 ml kg –1  h –1 , see above) together with normal saline 0.9% 
(4 ml kg –1  h –1 , for study drug administration) was given. The deci-
sion to use a 5% human albumin solution instead of a crystalloid 
solution was based on a previous experience from pilot studies, 
where pure crystalloid solution had been associated with difﬁ culties 
in achieving haemodynamic stability during reperfusion following 
unclamping. Fluid losses during laparotomy and the surgical prep-
aration were replaced with 24 ml kg –1  of HA. Following declamping 
of the aorta, 10 ml kg –1  of HA was infused over 3 min, followed by 
repeated boluses of 2–4 ml kg –1  of HA, and titrated to keep the ab-
dominal aortic blood ﬂ ow above 80% of the respective baseline 
values during the ﬁ rst 120 min of reperfusion. 
 Experimental Protocol 
 After 30 min recovery from surgery, the animals were random-
ly allocated to receive normal saline 0.9% (n = 6) or dopexamine 
(n = 6) at a dose of 3   g kg –1  min –1  given at a rate of 4 ml kg –1  h –1  
throughout the experimental procedure until 120 min of reperfu-
sion. After 30 min of infusion, the abdominal aorta above the co-
eliac artery was clamped for 30 min. Following declamping, the 
animals were observed for 180 min of reperfusion and then eutha-
nized with intravenous pentobarbital (100 mg). The correct posi-
tion of catheters and ﬂ ow probes was conﬁ rmed by autopsy. 
 Measurements 
 Fifteen minutes after the end of the surgical preparation, the 
tonometer balloon was ﬁ lled with 0.6 ml of phosphate-buffered so-
lution (Na 2 HPO 4 /NaH 2 PO 4 ). Thirty minutes after the end of the 
surgical preparation, baseline measurements of MAP, heart rate 
(HR) and blood ﬂ ows (carotid artery, abdominal aortic, superior 
mesenteric artery) were recorded. A quantity of 0.3 ml of tonom-
eter balloon ﬂ uid was aspirated and discarded as dead space. The 
remaining 0.3 ml ﬂ uid was aspirated using a 1-ml syringe and im-
mediately analyzed for PCO 2  (Model IL 1302, Instrumentation 
Laboratory Systems Inc., Lexington, Mass., USA). A quantity of 
0.3 ml of blood was sampled from the carotid artery, right atrium 
and the portal vein. Before sampling the blood for analysis, 0.2 ml 
of dead space of catheters was aspirated and reinjected following 
aspiration of the blood samples. The sampled blood volume was 
replaced following each measurement with 1 ml of blood which was 
harvested the same day from a donor rat. Catheters were then 
ﬂ ushed with 0.2 ml of heparinized (2.5 U of bovine heparin per 
1 ml) physiologic saline solution. All samples were analyzed for 
haemoglobin concentration, oxygen saturation (OSM3, Hemoxim-
eter, Radiometer, Copenhagen, Denmark) and lactate concentra-
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tion (2300 Stat Plus, Lactate Analyzer, YSI Inc., Ohio, USA). In 
the arterial sample, a blood gas analysis was performed (Model IL 
1302, Instrumentation Laboratory Systems Inc.). Measurements 
and samplings were performed at baseline, 30 min following the 
start of the infusion of dopexamine or saline 0.9%, 30 min follow-
ing aortic cross-clamping, and 15, 30, 60, 120 and 180 min follow-
ing declamping. 
 Calculations 
 Oxygen deliveries and oxygen consumption were calculated us-
ing blood ﬂ ows indexed to body weight. Calculation of oxygen con-
tent of arterial (CaO 2 ) as well as portal venous blood (CpvO 2 ) did 
not take into account the amount of dissolved oxygen, since a blood 
gas analysis was not performed in the portal venous sample. 
 Oxygen content of blood (ml O 2  ml –1 ) was calculated as: 
 haemoglobin concentration [g (100 ml) –1 ]  ! O 2  saturation 
(100) –1   ! (1.34 ml O 2 ) g –1 .  
 Abdominal aortic oxygen delivery (ml O 2  min –1  kg –1 ) was cal-
culated as:  abdominal aortic blood ﬂ ow (ml min –1  kg –1 )  ! CaO 2  
(ml O 2  ml –1 ). 
 Mesenteric oxygen delivery (ml O 2  min –1  kg –1 ) was calculated 
as:  mesenteric blood ﬂ ow (ml min –1  kg –1 )  ! CaO 2  (ml O 2  ml –1 ). 
 Mesenteric oxygen consumption (ml O 2  min –1  kg –1 ) was calcu-
lated as:  mesenteric blood ﬂ ow (ml min –1  kg –1 )  ! [CaO 2  – CpvO 2  
(ml O 2  ml –1 )]. 
 Mesenteric oxygen extraction ratio (%) was calculated as:  mes-
enteric oxygen consumption/mesenteric oxygen delivery  ! 100. 
 Regarding tonometric measurements and calculations, the mea-
surements of PCO 2  in the phosphate buffer solution from the to-
nometric balloon were corrected with the factor 1.17 and named 
PtCO 2 . This correction factor, which is different from the correc-
tion factors provided by the manufacturer, was determined from 
our own in vitro study  [18] , as the equilibration of PCO 2  over the 
silicon balloon membrane is incomplete after 15 min. The PCO 2  
gap was calculated as the difference of tonometric minus arterial 
PCO 2  (PtCO 2  – PaCO 2 ). 
 Statistical Analysis 
 All data presented in tables and ﬁ gures represent mean  8 stan-
dard deviation (SD). Comparisons of different time points versus 
baseline within one group were performed using ANOVA for re-
peated measurements, followed by Dunnett’s post test. Differences 
between two groups at the same time points were analyzed using 
Student’s t test. (GraphPad InStat, version 2.02, San Diego, Calif., 
USA). 
 Results 
 Effects prior to Aortic Cross-Clamping 
 Thirty minutes infusion of dopexamine induced a sig-
niﬁ cant increase in heart rate in the dopexamine group, 
different from the control group ( table 1 ). 
 Effects during Aortic Cross-Clamping 
 Thirty minutes of aortic cross-clamping increased 
MAP in both groups and decreased HR in the control 
group, whereas it remained elevated in the dopexamine 
group. Carotid blood ﬂ ow increased in the control group 
( table 1 ). Increases in right atrial haemoglobin oxygen 
saturation were comparable between the two groups ( ta-
ble 2 ). Arterial lactate concentration ( ﬁ g. 1 ) and PtCO 2  
( table 3 ) increased in both groups, but to higher levels in 
the dopexamine group. The PCO 2  gap tended to be high-
er in the dopexamine group (p = 0.12). Arterial pH 
 decreased to a lower level in the dopexamine group ( ta-
ble 3 ). 
Table 1. Haemodynamic parameters in the control (CON, n = 6) or dopexamine (DX, n = 6) group
Variable BL D30 C30 R15 R30 R60 R120 R180
Mean arterial pressure CON 12388 125815 15886a 9587a 98813a 88814a 77813a 62812a
mm Hg DX 118817 127811 151810a 98815a 96817a 89820a 82822a 67815a
Heart rate CON 400841 400845 350825a 355823a 365835a 378833 370825a 365823a
beats min–1 DX 410849 485830a, b 460825a, b 415835b 430845b 430856 430868 405878
Aortic artery blood ﬂ ow CON 156818 153817 182832a 161830 137820 144821 118831a
ml min–1 kg–1 DX 150813 163838 164822 148819 130813 141821 112827a
Mesenteric artery blood ﬂ ow CON 37812 36811 67815a 52811a 3887 4387 33811
ml min–1 kg–1 DX 3585 3788 5989a 4388 39817 44819 3088
Carotid artery blood ﬂ ow CON 1688 1686 2185a 1484 1184a 1084a 1286a 1085a
ml min–1 kg–1 DX 18811 1487 2089 1488 1186a 1085a 1285a 1084a
Values are mean 8 SD. BL = Baseline; D30 = after 30 min of dopexamine or saline infusion; C30 = after 30 min of aortic cross-
clamping; R15 to R180 = after 15–180 min of reperfusion. 
a p < 0.05 versus baseline; b p < 0.05, CON versus DX.
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 Effects during Reperfusion following Declamping 
 MAP decreased in both groups and remained lowered 
during the reperfusion period. HR remained lowered in 
the control group and returned to baseline levels in the 
dopexamine group. Aortic blood ﬂ ow was kept above 
80% of baseline values during 120 min of reperfusion, 
driven by the ﬂ uid resuscitation protocol, and required 
identical amounts of ﬂ uid to reach target values (30  8 
11 ml kg –1  in the control group and 36  8 16 ml kg –1  in 
the dopexamine group; p = 0.46). During further reperfu-
sion, aortic blood ﬂ ow decreased in both groups below 
baseline values when the infusion of ﬂ uid was reduced to 
12 ml kg –1  h –1 . Aortic oxygen delivery steadily decreased 
in both groups to 75% of baseline values mainly due to 
haemodilution effects (accounting for approximately 
60% of the decrease in aortic oxygen delivery) and further 
dropped to 62% of baseline when ﬂ uid resuscitation was 
reduced ( table 2 ). Right atrial oxygen saturation decreased 
comparably in both groups, indicating increased oxygen 
extraction ( table 2 ). Mesenteric blood ﬂ ow was higher 
than at baseline early following declamping and decreased 
steadily towards baseline values during further reperfu-
sion in both groups. The resulting mesenteric oxygen de-
livery remained preserved around baseline levels, with 
the exception of the increase immediately following 
declamping ( table 2 ). Mesenteric oxygen uptake remained 
preserved throughout the reperfusion period. The result-
ing mesenteric oxygen extraction ratio dropped signiﬁ -
cantly in the control group immediately following 
declamping and recovered to baseline levels during fur-
ther reperfusion. Carotid blood ﬂ ow was decreased below 
baseline values during the entire reperfusion period in 
Table 2. Oxygen transport parameters in the control (CON, n = 6) or dopexamine (DX, n = 6) group
Variable BL D30 C30 R15 R30 R60 R120 R180
Aortic O2 delivery CON 28.384.2 26.882.7 26.384.4 25.384.1 22.082.8* 21.182.8* 17.784.6*
ml O2 min–1 kg–1 DX 27.583.4 29.986.6 24.984.6 23.583.8 20.782.8* 21.083.9* 17.184.6*
Mesenteric O2 delivery CON 6.782.2 6.381.9 9.882.8* 8.281.7 6.181.2 6.380.8 5.081.6
ml O2 min–1 kg–1 DX 6.481.2 6.881.6 8.581.9* 7.081.9 6.182.4 6.582.9 4.681.4
Mesenteric O2 uptake CON 0.980.3 0.980.4 0.680.2 0.680.3 0.680.2 0.680.2 0.680.3
ml O2 min–1 kg–1 DX 0.880.1 0.880.3 0.880.3 0.880.3 0.980.4 0.780.3 0.780.3
Mesenteric oxygen CON 1486 1587 683* 985 1084 1084 1488
extraction rate, % DX 1383 1282 985 1182 1586 1286 1685
Haemoglobin CON 13.681.2 13.2810 12.5811 11.380.6* 12.085* 12.380.7* 11.689* 11.780.9*
g 100 ml–1 DX 13.881.0 13.980.6 12.980.5 11.880.9* 12.181.3* 12.180.8* 11.581.0* 11.881.0*
Right atrial O2 CON 7284 6985 9087* 65810 61810* 5886* 5785* 56810*
saturation, % DX 7084 6489 8787* 60814 57812* 5388* 5589* 5485*
Values are mean 8 SD. BL = Baseline; D30 = after 30 min of dopexamine or saline infusion; C30 = after 30 min of aortic cross-
clamping; R15 to R180 = after 15–180 min of reperfusion.*  p < 0.05 versus baseline.
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 Fig. 1. Arterial lactate concentration in the control (mean – SD, 
n = 6) or dopexamine group (mean + SD, n = 6) at baseline (BL), 
after 30 min of dopexamine or saline infusion (D30), after 30 min 
of supracoeliac aortic cross-clamping (C30), and after 15–180 min 
of reperfusion (R15–R180) following declamping.  a  p  ! 0.05, con-
trol versus dopexamine group;  b  p  ! 0.05 versus baseline. 
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both groups. The dopexamine group differed from the 
control group by the transiently higher values of arterial 
lactate concentration, PtCO 2  and PCO 2  gap early follow-
ing declamping ( table 3 ;  ﬁ g. 1 ). 
 Discussion 
 The main ﬁ nding of this experimental study is that 
dopexamine, infused during aortic cross-clamping, is as-
sociated with higher blood lactate levels and higher to-
nometer PCO 2  during induced ischaemia by aortic cross-
clamping and during the ﬁ rst 15 min of reperfusion fol-
lowing declamping. We conﬁ rmed the ﬁ nding of higher 
lactate levels from our previous study  [16] , where we had 
given a higher dose of dopexamine (10 vs. 3   g kg –1  
min –1  in the present study) and lesser ﬂ uid during reper-
fusion. Since increased plasma levels of lactate may prin-
cipally depend on increased production or decreased me-
tabolism and clearance, primarily by the liver, several 
potential mechanisms may account for the observed dif-
ferences in the dopexamine group. 
 First, there is a systemic, metabolic effect, mediated 
by adrenergic receptors, and acting on all tissues, which 
are susceptible to adrenergic stimulation. Systemic meta-
bolic effects have been demonstrated for dopexamine 
 [14] , noradrenaline, adrenaline and dopamine  [13] in 
awake, healthy volunteers. These metabolic effects result-
ed in an increased systemic oxygen uptake without an 
increase in lactate. In contrast to these data from healthy, 
unstressed subjects, dopexamine at moderate doses in-
duced a reversible increase in systemic oxygen uptake 
together with an increase in lactate levels  [19] in patients 
immediately following cardiopulmonary bypass. Most of 
the recent data regarding metabolic effects of adrenergic 
drugs come from experimental and clinical studies in sep-
sis, where the effects of adrenergic drugs on metabolism, 
perfusion and lactate generation are complex  [15] and 
may not apply to our model. We did not measure sys-
temic oxygen uptake in our model, but we may assume 
that right atrial oxygen saturation reﬂ ects changes in sys-
temic oxygen uptake, if aortic blood ﬂ ow and haemoglo-
bin do not change. In fact, our results do not show sig-
niﬁ cant differences in right atrial haemoglobin oxygen 
saturation between the two groups at identical values for 
aortic blood ﬂ ow and haemoglobin, which suggests that 
dopexamine has no major effects on systemic oxygen up-
take. 
 Second, there is a regional, metabolic effect due to do-
pexamine treatment in tissues distal to the aortic cross-
clamp, enhancing ischaemia during the period of induced 
ischaemia by aortic cross-clamping. This effect would af-
fect not only the visceral organs, but also tissues of the 
lower body, which are not supplied by collateral blood 
ﬂ ow. In contrast to our previous study, we demonstrated 
signiﬁ cantly higher intestinal tonometer PCO 2  values 
during ischaemia, induced by aortic cross-clamping, as 
well as during early reperfusion following declamping in 
the dopexamine group. Higher intestinal tonometer PCO 2  
values in the dopexamine group suggest that more an-
aerobic metabolism occurs within the intestinal mucosa 
and that part of the increased lactate might be generated 
Table 3. Tonometer and blood gas parameters in the control (CON, n = 6) or dopexamine (DX, n = 6) group
Variable BL D30 C30 R15 R30 R60 R120 R180
PtCO2 CON 6.080.7 6.580.2 10.580.7a 8.180.4a 6.980.4a 6.480.7 7.180.5a 7.580.7a
kPa DX 6.180.5 6.780.3 11.680.6a, b 8.980.6a, b 7.881.4a 7.080.4 7.580.5a 7.580.6a
PCO2 gap CON 1.480.5 1.380.5 6.781.0a 2.780.5a 2.080.4 1.580.7 1.880.2 2.180.8
kPa DX 1.580.8 1.580.6 7.580.5a 3.480.3a, b 3.181.4a 2.080.4 2.380.7 2.180.8
PCO2 arterial CON 4.780.4 5.180.5 3.880.4a 5.480.4 5.080.5 5.080.3 5.380.5 5.480.6
kPa DX 4.680.4 5.180.4 4.180.3a 5.580.5 4.880.3 5.080.4 5.280.5 5.480.3
pH art CON 7.4080.03 7.3780.04 7.4180.05 7.1980.03a 7.2380.02a 7.2580.03a 7.2580.02a 7.2380.02a
units DX 7.3980.04 7.3480.05a 7.2780.06a, b 7.1280.06a, b 7.1880.05a 7.2280.07a 7.2480.05a 7.2180.04a
Values are mean 8 SD. BL = Baseline; D30 = after 30 min of dopexamine or saline infusion; C30 = after 30 min of aortic cross-
clamping; R15 to R180 = after 15–180 min of reperfusion. 
a p < 0.05 versus baseline; b p < 0.05, CON versus DX.
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within the splanchnic region. There is supporting evi-
dence from an experimental model in pigs  [20] , in which 
a combination of measurements including jejunal laser 
Doppler ﬂ owmetry, microoxymetry, mucosal PCO 2  to-
nometry and luminal microdialysis for lactate, pyruvate 
and glucose was applied. By inducing graded mesenteric 
hypoperfusion, it could be demonstrated that dopex-
amine induced increased mesenteric lactate production 
below a perfusion pressure of 30 mm Hg despite having 
favourable effects on mesenteric blood ﬂ ow. Combining 
ﬂ ow measurements with metabolic measurements at the 
regional level added information to this study, which 
would have been missed. Whether intestinal CO 2  tonom-
etry represents a precise tool to evaluate regional splanch-
nic ischaemia is widely debated  [21] , but nevertheless, it 
is applied in numerous clinical and experimental studies. 
Increased accuracy of measurements may be achieved 
using a phosphate-buffered solution  [22] as well as calcu-
lating the PCO 2  gap which better reﬂ ects splanchnic isch-
aemia  [23–25] , instead of intramural pH which may vary, 
depending on systemic arterial PCO 2 . Alternatively, mes-
enteric ischaemia can be estimated using polarographic 
electrodes to measure surface oxygen tension. Using both 
polarographic and tonometric methods, we previously 
demonstrated in pigs a linear relationship between chang-
es in intramural pH and changes in jejunal serosal and 
mucosal surface oxygen tensions, when mesenteric ﬂ ow 
was gradually reduced  [26] . Similar ﬁ ndings are reported 
from a study in dogs, using hypocapnia as a vasoconstrict-
ing stimulus  [27] . 
 Third, collateral blood ﬂ ow to the ischaemic tissues 
distal to the aortic cross-clamp might have been decreased 
by dopexamine, either by systemic vasodilatation, as 
demonstrated in earlier studies using nitroprussid  [28] , 
or by effects on microvascular blood ﬂ ow distribution, as 
demonstrated using prostaglandin during aortic cross-
clamping  [29] . Since we found identical values for MAP 
in both groups, we have no evidence that vasodilating ef-
fects of dopexamine proximal to the clamp might have 
decreased collateral blood ﬂ ow by decreasing perfusion 
pressure. Distal to the clamp, microvascular effects may 
well have occurred within the splanchnic area, as de-
scribed above, and may not be excluded in other tis-
sues. 
 Finally, metabolism of dopexamine might be severely 
disturbed during supracoeliac cross-clamping, since the 
liver plays a signiﬁ cant role in the clearance of dopex-
amine. Up to a fourfold increase in plasma concentra-
tions has been measured in patients undergoing orthoptic 
liver transplantation during the anhepatic phase  [30] . Ac-
cordingly, liver ischaemia during the period of supracoe-
liac aortic cross-clamping might therefore result in higher 
plasma levels of dopexamine, which may have effects on 
tissues proximal to the clamp. These effects may differ 
from those observed during the preclamp period and may 
probably affect cardiac metabolism. In our model, dopex-
amine induces an increase in heart rate without a con-
comitant increase in aortic and carotid blood ﬂ ow; further 
chronotropic stimulation may therefore not be tolerated 
adequately. We do not know whether myocardial blood 
ﬂ ow was enhanced and whether myocardial oxygen con-
sumption was increased. However, the experimental de-
sign of our study does not allow drawing conclusions on 
cardiac function in the absence of differences in mea-
sured variables except heart rate. 
 Further reperfusion following the early period of 
30 min after declamping demonstrated no differences be-
tween the dopexamine and the control group. In contrast 
with our previous study  [16] , lactate levels recovered to 
baseline levels within 2 h of reperfusion in both groups, 
most probably due to higher amounts of intravenous 
ﬂ uid. 
 Favourable effects of dopexamine on organ damage 
are reported from experimental studies, probably due to 
dopexamine-associated anti-inﬂ ammatory properties 
 [31] , or by prevention of free radical formation  [32] . 
These effects would not have been evident in our model, 
since the observation period was too short. However, 
these mechanisms may well be involved to explain the 
protective effect on colonic mucosa, which are described 
in patients undergoing aortic surgery  [9] . 
 This study is limited by several factors. First, using a 
rodent model, which is economically attractive, may lim-
it the number of monitoring devices being applied simul-
taneously and the amount of blood sampling due to the 
size of the animals. Furthermore, complex surgical prep-
arations and protocols induce haemodynamic changes, 
which are easier to control in larger animals. Variability 
of results may therefore be greater than expected and re-
quires larger series. Second, our data and similar ﬁ ndings 
during graded mesenteric hypoperfusion  [20] result from 
experimental studies in animals, and conclusions for the 
clinical setting may not be drawn. Moreover, the observed 
effects associated with dopexamine treatment are limited 
to the induced ischaemic and the immediate reperfusion 
period and may therefore not be of clinical importance. 
 In conclusion, during supracoeliac aortic cross-clamp-
ing, we demonstrated that dopexamine was associated 
with higher values of arterial lactate and intestinal tono-
metric PCO 2 . This ﬁ nding may be explained by complex 
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interactions of dopexamine effects and the effects of aor-
tic cross-clamping, occurring systemically, as well as re-
gionally. The signiﬁ cance of this ﬁ nding remains un-
clear. 
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